All stock lists
Hasbro, Inc. (NASDAQ:HAS)
US · Delayed Price · Currency is USD
Also listed: 0J3K.LConsumer Cyclical · Leisure
117.96+0.52 (+0.44%)
Market cap
$16.6B
Health Score
Analyst consensus
Listed since
Mar 17, 1980
Website
Insider Score
––Not scored
HAS Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
HAS analyst forecast
HAS analyst consensus
Moderate Buy3 ratings
Buy 2 Hold 1 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
HAS 12-month price target
$110.20-6.6% downsideaverage of 5 firms
$122.00High
$90.00Low
Best analysts covering HAS
- Citigroup100%success rate · 4 calls
- JP Morgan100%success rate · 4 calls
- Roth Capital100%success rate · 1 call
- Goldman Sachs100%success rate · 1 call
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
HAS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-21 |
| — | BNP Paribas | Outperform | — | — | Reiterated | 2026-10-21 |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-10-21 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-10-13 |
| Wells Fargo | Equal Weight | $90.00 | -3.6% | Reiterated | 2026-08-20 | |
| UBS | — | $120.00 | +34.4% | — | 2026-07-27 | |
| — | Argus Research | Buy | — | — | Reiterated | 2026-07-23 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-07-22 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-07-22 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-07-16 |
| — | Jefferies | Buy | — | — | Reiterated | 2026-07-16 |
| — | BNP Paribas | Outperform | — | — | Reiterated | 2026-07-15 |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-07-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-07-10 |
| UBS | — | $110.00 | +29.8% | — | 2026-06-18 | |
| — | Wells Fargo | Equal Weight | — | — | Reiterated | 2026-06-09 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-05-22 |
| — | B of A Securities | Buy | — | — | Reiterated | 2026-05-21 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-05-21 |
| Wells Fargo | Equal Weight | $92.00 | +3.8% | Reiterated | 2026-05-21 | |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-14 |
| Morgan Stanley | Overweight | $122.00 | +26.3% | Reiterated | 2026-04-24 | |
| — | BNP Paribas | Outperform | — | — | Reiterated | 2026-04-01 |
| Argus Research | — | $105.00 | +10.4% | — | 2026-03-13 | |
| — | UBS | Buy | — | — | Reiterated | 2026-03-05 |
| — | Citigroup | Buy | — | — | Reiterated | 2026-02-12 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2026-02-11 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2026-02-11 |
| Goldman Sachs | Buy | $114.00 | +9.6% | Reiterated | 2026-02-11 | |
| — | Roth Capital | Buy | — | — | Reiterated | 2026-02-04 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-02-02 |
| — | UBS | Buy | — | — | Reiterated | 2026-01-07 |
| Morgan Stanley | — | $94.00 | +15.3% | — | 2025-12-14 | |
| — | UBS | Buy | — | — | Reiterated | 2025-11-14 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-10-24 |
| Roth Capital | — | $96.00 | +23.2% | — | 2025-10-24 | |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-09-29 |
| — | UBS | Buy | — | — | Reiterated | 2025-08-13 |
| — | Citigroup | Buy | — | — | Reiterated | 2025-07-24 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-07-24 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2025-07-24 |
| — | Roth Capital | Buy | — | — | Reiterated | 2025-07-24 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-07-24 |
| — | B of A Securities | Buy | — | — | Reiterated | 2025-07-17 |
| Goldman Sachs | Buy | $85.00 | +15.1% | Upgraded | 2025-07-01 | |
| — | Citigroup | Buy | — | — | Reiterated | 2025-06-16 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-05-29 |
| D.A. Davidson | — | $75.00 | +15.0% | — | 2025-05-14 | |
| — | Citigroup | Buy | — | — | Upgraded | 2025-04-25 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-04-25 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-04-23 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2025-02-24 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-02-21 |
| — | Roth MKM | Buy | — | — | Reiterated | 2025-02-21 |
| — | Roth MKM | Buy | — | — | Reiterated | 2025-01-15 |
| — | Stifel | Buy | — | — | Reiterated | 2025-01-03 |
| — | JP Morgan | Overweight | — | — | Reiterated | 2024-10-25 |
| — | DA Davidson | Neutral | — | — | Reiterated | 2024-10-25 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2024-10-25 |
HAS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-05-20 | 1.20 | 1.47 | $969.2M | $1.00B |
| 2026-07-21 | 1.16 | 1.28 | $1.07B | $1.14B |
| 2026-10-20 | 1.86 | 2.90 | $1.48B | $1.60B |
| 2027-02-09 | 1.50 | 0.00 | $1.44B | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.